Crossref journal-article
Oxford University Press (OUP)
Human Molecular Genetics (286)
Bibliography

Catoire, H., Pasco, M. Y., Abu-Baker, A., Holbert, S., Tourette, C., Brais, B., Rouleau, G. A., Parker, J. A., & Néri, C. (2008). Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1. Human Molecular Genetics, 17(14), 2108–2117.

Authors 9
  1. Hélène Catoire (first)
  2. Matthieu Y. Pasco (additional)
  3. Aida Abu-Baker (additional)
  4. Sébastien Holbert (additional)
  5. Cendrine Tourette (additional)
  6. Bernard Brais (additional)
  7. Guy A. Rouleau (additional)
  8. J. Alex Parker (additional)
  9. Christian Néri (additional)
References 54 Referenced 51
  1. 10.1159/000072861 / Cytogenet.Genome Res. / Oculopharyngeal muscular dystrophy: a late-onset polyalanine disease by Brais (2003)
  2. 10.1038/ng0298-164 / Nat. Genet. / Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. [Erratum (1998) Nat Genet, 19, 404.] by Brais (1998)
  3. 10.1006/jmbi.2000.3572 / J Mol Biol / The nuclear poly(A) binding protein, PABP2, forms an oligomeric particle covering the length of the poly(A) tail. by Keller (2000)
  4. 10.1017/S1355838200991908 / Rna / Deciphering the cellular pathway for transport of poly(A)-binding protein II by Calado (2000)
  5. 10.1093/hmg/10.11.1129 / Hum. Mol. Genet. / The product of an oculopharyngeal muscular dystrophy gene, poly(A)- binding protein 2, interacts with SKIP and stimulates muscle-specific gene expression by Kim (2001)
  6. 10.1002/1531-8249(200011)48:5<812::AID-ANA20>3.0.CO;2-2 / Ann. Neurol. / Intranuclear inclusions in oculopharyngeal muscular dystrophy contain poly(A) binding protein 2 by Becher (2000)
  7. 10.1093/hmg/ddh017 / Hum. Mol. Genet. / Myopathy phenotype in transgenic mice expressing mutated PABPN1 as a model of oculopharyngeal muscular dystrophy by Hino (2004)
  8. 10.1074/jbc.M109633200 / J. Biol. Chem. / Mammalian, yeast, bacterial, and chemical chaperones reduce aggregate formation and death in a cell model of oculopharyngeal muscular dystrophy by Bao (2002)
  9. 10.1093/hmg/ddg293 / Hum. Mol. Genet. / Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy by Abu-Baker (2003)
  10. 10.1093/hmg/ddh101 / Hum. Mol. Genet. / Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus by Berciano (2004)
  11. 10.1261/rna.7217105 / Rna / In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1 by Tavanez (2005)
  12. 10.1016/j.nbd.2007.02.004 / Neurobiol. Dis. / Soluble expanded PABPN1 promotes cell death in Oculopharyngeal muscualr dystrophy by Messaed (2007)
  13. 10.1093/oxfordjournals.hmg.a018924 / Hum. Mol. Genet. / Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA by Calado (2000)
  14. 10.1016/j.nbd.2004.10.019 / Neurobiol. Dis. / PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions by Corbeil-Girard (2005)
  15. 10.1016/j.bbadis.2006.10.003 / Biochim. Biophys. Acta / Oculopharyngeal muscular dystrophy: Recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies by Abu-Baker (2007)
  16. 10.1093/hmg/ddi458 / Hum. Mol. Genet. / Rapamycin alleviates toxicity of different aggregate-prone proteins by Berger (2006)
  17. 10.1074/jbc.M509329200 / J. Biol. Chem. / SIRT1 protects against microglia-dependent beta amyloid toxicity through inhibiting NF-kappa B signaling by Chen (2005)
  18. 10.1126/science.1124646 / Science / Opposing activities protect against age-onset proteotoxicity by Cohen (2006)
  19. 10.1038/ng1534 / Nat. Genet. / Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons by Parker (2005)
  20. 10.1038/nature05291 / Nature / The roles of intracellular protein-degradation pathways in neurodegeneration by Rubinsztein (2006)
  21. 10.1038/nature05354 / Nature / Resveratrol improves health and survival of mice on a high-calorie diet by Baur (2006)
  22. 10.1016/j.cell.2006.11.013 / Cell / Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha by Lagouge (2006)
  23. 10.1073/pnas.0610068104 / Proc. Natl. Acad. Sci. USA / Resveratrol stimulates AMP kinase activity in neurons by Dasgupta (2007)
  24. 10.1093/genetics/135.2.385 / Genetics / Sequence requirements for myosin gene expression and regulation in Caenorhabditis elegans by Okkema (1993)
  25. 10.1016/S0014-5793(99)01651-8 / FEBS Lett. / Mutations in the dystrophin-like dys-1 gene of Caenorhabditis elegans result in reduced acetylcholinesterase activity by Giugia (1999)
  26. 10.1073/pnas.112213799 / Proc. Natl. Acad. Sci. USA / SKIP is an indispensable factor for Caenorhabditis elegans development by Kostrouchova (2002)
  27. 10.1128/JVI.74.4.1939-1947.2000 / J. Virol. / A role for SKIP in EBNA2 activation of CBF1-repressed promoters by Zhou (2000)
  28. 10.1038/nm1479 / Nat. Med. / Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors by Minetti (2006)
  29. 10.1007/s00439-006-0186-1 / Hum. Genet. / The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells by Riessland (2006)
  30. 10.1016/j.cell.2006.07.002 / Cell / Sirtuins in aging and age-related disease by Longo (2006)
  31. 10.1074/jbc.M602909200 / J. Biol. Chem / Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction by Qin (2006)
  32. 10.1038/35065638 / Nature / Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans by Tissenbaum (2001)
  33. 10.1073/pnas.152161099 / Proc. Natl. Acad. Sci. USA / The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans by Morley (2002)
  34. 10.1101/gad.1255404 / Genes Dev. / The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans by Apfeld (2004)
  35. 10.1074/jbc.M705325200 / J. Biol. Chem. / The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor by Greer (2007)
  36. 10.2174/156800907780006922 / Curr. Cancer Drug Targets / Small molecule inhibitors of Stat3 signaling pathway by Deng (2007)
  37. 10.1038/nature01960 / Nature / Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan by Howitz (2003)
  38. 10.1074/jbc.M508246200 / J. Biol. Chem. / Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides by Marambaud (2005)
  39. 10.1016/j.cub.2005.12.038 / Curr. Biol. / Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate by Valenzano (2006)
  40. 10.1073/pnas.261574398 / Proc. Natl. Acad. Sci. USA / Identification of a small molecule inhibitor of Sir2p by Bedalov (2001)
  41. 10.1038/nature02998 / Nature / Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death by Arrasate (2004)
  42. 10.1038/ng1977 / Nat. Genet. / Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes by Bowman (2007)
  43. 10.1126/science.1098014 / Science / Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration by Araki (2004)
  44. 10.1126/science.1143780 / Science / Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease by Outeiro (2007)
  45. 10.1016/j.cub.2007.01.008 / Curr. Biol. / FOXO transcription factors by Carter (2007)
  46. 10.4161/auto.5905 / Autophagy / Downstream of Akt: FoxO3 and mTOR in the regulation of autophagy in skeletal muscle by Mammucari (2008)
  47. 10.1016/j.cmet.2007.11.004 / Cell Metab. / FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells by Zhao (2007)
  48. 10.1016/S0092-8674(04)00400-3 / Cell / Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy by Sandri (2004)
  49. 10.1152/ajpcell.00542.2005 / Am. J. Physiol. Cell Physiol. / Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors by Allen (2007)
  50. 10.1016/0022-2836(84)90023-8 / J. Mol. Biol. / Dominant mutations affecting muscle structure in Caenorhabditis elegans that map near the actin gene cluster by Waterston (1984)
  51. 10.1016/j.cell.2006.04.036 / Cell / C. elegans SIR-2.1 interacts with 14-3-3 proteins to activate DAF-16 and extend life span by Berdichevsky (2006)
  52. 10.1128/MCB.26.8.3085-3097.2006 / Mol. Cell. Biol. / Evidence that poly(A) binding protein C1 binds nuclear pre-mRNA poly(A) tails by Hosoda (2006)
  53. {'key': 'key\n\t\t\t\t20170522152649_DDN109C53', 'article-title': 'In The C. elegans Research Community Immunohistochemistry (June 19, 2006)', 'author': 'Duerr', 'year': '2006', 'journal-title': 'WormBook'} / WormBook / In The C. elegans Research Community Immunohistochemistry (June 19, 2006) by Duerr (2006)
  54. 10.1007/s002800100300 / Cancer Chemother. Pharmacol. / Histone deacetylase as a new target for cancer chemotherapy by Yoshida (2001)
Dates
Type When
Created 17 years, 4 months ago (April 8, 2008, 8:13 p.m.)
Deposited 3 years, 11 months ago (Sept. 7, 2021, 10:55 a.m.)
Indexed 1 year, 2 months ago (June 4, 2024, 7:31 p.m.)
Issued 17 years, 4 months ago (April 7, 2008)
Published 17 years, 4 months ago (April 7, 2008)
Published Online 17 years, 4 months ago (April 7, 2008)
Published Print 17 years, 1 month ago (July 15, 2008)
Funders 0

None

@article{Catoire_2008, title={Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1}, volume={17}, ISSN={0964-6906}, url={http://dx.doi.org/10.1093/hmg/ddn109}, DOI={10.1093/hmg/ddn109}, number={14}, journal={Human Molecular Genetics}, publisher={Oxford University Press (OUP)}, author={Catoire, Hélène and Pasco, Matthieu Y. and Abu-Baker, Aida and Holbert, Sébastien and Tourette, Cendrine and Brais, Bernard and Rouleau, Guy A. and Parker, J. Alex and Néri, Christian}, year={2008}, month=apr, pages={2108–2117} }